About this FactMed analysis covering adverse side effect reports of ADENINE patients who developed FIBROMYALGIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ADENINE reported FIBROMYALGIA to the FDA. A total of 12 ADENINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ADENINE and FIBROMYALGIA. In doing so, we compare ADENINE with other drugs that cause FIBROMYALGIA, to help you evaluate whether or not ADENINE causes FIBROMYALGIA. Likewise, this page shows the most highly-reported side effects of ADENINE, so you can see if FIBROMYALGIA ranks among ADENINE's most well-known side effects.
Summary Statistics
Reports of ADENINE causing FIBROMYALGIA: 1
Reports of any side effect of ADENINE : 12
Percentage of ADENINE patients where FIBROMYALGIA is a reported side effect: 8.3333%

FDA reports of any drug causing FIBROMYALGIA : 6425
Average percentage for all medicated patients where FIBROMYALGIA is reported as a complication: 0.0403%

Physician opinion on ADENINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ADENINE:
VITAMIN SUPPLEMENTATION ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
( 0 patients )
Drugs with high FDA adverse event association with FIBROMYALGIA:

FOSAMAX (1848 patients)
VIOXX (1685 patients)
LYRICA (1127 patients)
NEURONTIN (531 patients)
CYMBALTA (529 patients)
LIPITOR (494 patients)
NEXIUM (493 patients)
SEROQUEL (488 patients)
ASPIRIN (452 patients)
CELEBREX (438 patients)
XANAX (412 patients)
ZOLOFT (395 patients)
ENBREL (394 patients)
SYNTHROID (337 patients)
PREDNISONE (326 patients)
AVONEX (315 patients)
PRILOSEC (300 patients)
VICODIN (288 patients)
ACCUTANE (281 patients)
HUMIRA (274 patients)
FOSAMAX PLUS D (273 patients)
METHOTREXATE (264 patients)
AMBIEN (262 patients)
TOPROL-XL (260 patients)
PREMARIN (259 patients)
PREVACID (255 patients)
LISINOPRIL (253 patients)
KLONOPIN (250 patients)
FOLIC ACID (248 patients)
PERCOCET (247 patients)
ZOCOR (229 patients)
EFFEXOR (228 patients)
OXYCONTIN (227 patients)
PROZAC (226 patients)
FLEXERIL (224 patients)
ELAVIL (224 patients)
VITAMIN D (224 patients)
DURAGESIC-100 (220 patients)
REMICADE (219 patients)
TYSABRI (214 patients)
FORTEO (210 patients)
ZOMETA (210 patients)
LASIX (208 patients)
CLONAZEPAM (208 patients)
CHANTIX (198 patients)
ATIVAN (197 patients)
COUMADIN (196 patients)
ATENOLOL (190 patients)
CRESTOR (189 patients)
LEXAPRO (186 patients)
GABAPENTIN (185 patients)
OMEPRAZOLE (179 patients)
PROTONIX (177 patients)
ULTRAM (176 patients)
ALENDRONATE SODIUM (175 patients)
LEVAQUIN (172 patients)
SIMVASTATIN (171 patients)
IBUPROFEN (169 patients)
PAXIL (168 patients)
OXYCODONE HCL (167 patients)
AREDIA (163 patients)
CALCIUM (161 patients)
BONIVA (161 patients)
AMITRIPTYLINE HCL (154 patients)
VALIUM (151 patients)
ALBUTEROL (151 patients)
SINGULAIR (150 patients)
ALPRAZOLAM (148 patients)
SOMA (145 patients)
PREDNISONE TAB (145 patients)
TOPAMAX (141 patients)
HYDROCHLOROTHIAZIDE (139 patients)
[THERAPY UNSPECIFIED] (138 patients)
ACTONEL (136 patients)
PLAVIX (130 patients)
POTASSIUM CHLORIDE (129 patients)
LORAZEPAM (129 patients)
LEVOTHYROXINE SODIUM (126 patients)
LORTAB (125 patients)
ZYPREXA (125 patients)
NORVASC (124 patients)
WELLBUTRIN (122 patients)
VITAMIN B-12 (121 patients)
ZYRTEC (120 patients)
FUROSEMIDE (118 patients)
EFFEXOR XR (116 patients)
BACLOFEN (116 patients)
CELEXA (114 patients)
SKELAXIN (112 patients)
PROVIGIL (112 patients)
METFORMIN HCL (111 patients)
VITAMINS (UNSPECIFIED) (111 patients)
ADVAIR DISKUS 100/50 (110 patients)
TRAZODONE HCL (109 patients)
BEXTRA (106 patients)
PREMPRO (106 patients)
CALCIUM (UNSPECIFIED) (103 patients)
PLAQUENIL (102 patients)
NITROGLYCERIN (102 patients)
TRAMADOL HCL (100 patients)
MORPHINE (99 patients)
DIAZEPAM (97 patients)
ACETAMINOPHEN (96 patients)
VITAMIN E (96 patients)
CIPROFLOXACIN (95 patients)
FLONASE (94 patients)
TRAZODONE HYDROCHLORIDE (94 patients)
HYDROCODONE BITARTRATE (94 patients)
MOTRIN (94 patients)
RISPERDAL (93 patients)
ARIMIDEX (93 patients)
TAMOXIFEN CITRATE (93 patients)
MIRALAX (93 patients)
BUSPAR (92 patients)
HALDOL (92 patients)
ZITHROMAX (91 patients)
TEGRETOL (90 patients)
REGLAN (90 patients)
DARVOCET (90 patients)
ZANAFLEX (89 patients)
OXYCODONE (89 patients)
DIOVAN (88 patients)
CLINDAMYCIN (87 patients)
RANITIDINE (87 patients)
AMITRIPTYLINE HYDROCHLORIDE (86 patients)
PROMETHAZINE (85 patients)
NAPROXEN (84 patients)
SPIRIVA (84 patients)
TYLENOL (CAPLET) (83 patients)
TYLENOL (80 patients)
FISH OIL (79 patients)
ASCORBIC ACID (79 patients)
ZETIA (78 patients)
MIRAPEX (78 patients)
MULTI-VITAMINS (78 patients)
XOLAIR (78 patients)
ALL OTHER THERAPEUTIC PRODUCTS (78 patients)
FENTANYL (78 patients)
LANTUS (78 patients)
GLUCOPHAGE (77 patients)
CALCIUM CARBONATE (77 patients)
DEPAKOTE (77 patients)
FEMARA (76 patients)
REBIF (74 patients)
LIDODERM (74 patients)
LOSARTAN POTASSIUM (73 patients)
VERAPAMIL (72 patients)
HYDROXYZINE (72 patients)
ZANTAC (72 patients)
MOBIC (70 patients)
CEPHALEXIN (70 patients)
DYAZIDE (68 patients)
AUGMENTIN '125' (68 patients)
HYDROCODONE (68 patients)
SYMBICORT (68 patients)
IMITREX (68 patients)
ESTRADIOL (68 patients)
ALLEGRA (67 patients)
COGENTIN (66 patients)
VITAMIN D (UNSPECIFIED) (66 patients)
WARFARIN SODIUM (65 patients)
KEFLEX (65 patients)
BYETTA (64 patients)
VISTARIL (64 patients)
XELODA (63 patients)
NASONEX (63 patients)
VALTREX (63 patients)
CIPRO (63 patients)
DIGOXIN (63 patients)
LIDOCAINE (63 patients)
FENTANYL TRANSDERMAL SYSTEM (62 patients)
CLARITIN (62 patients)
INSULIN (62 patients)
COMBIVENT (61 patients)
NORCO (60 patients)
ZELNORM (60 patients)
VYTORIN (60 patients)
REMERON (60 patients)
COMPAZINE (60 patients)
DARVOCET-N 100 (59 patients)
CLONIDINE (58 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (58 patients)
BENADRYL (58 patients)
ALTACE (58 patients)
SEROQUEL XR (57 patients)
CORTISONE (57 patients)
METHADONE HCL (57 patients)
PEPCID (56 patients)
COZAAR (56 patients)
RECLAST (56 patients)
PROPRANOLOL (54 patients)
METOCLOPRAMIDE (54 patients)
HUMALOG (54 patients)
PEGASYS (54 patients)
MELOXICAM (53 patients)
COLACE (53 patients)
MIRTAZAPINE (52 patients)
TRICOR (52 patients)
PREGABALIN (52 patients)
ZOFRAN (52 patients)
ACIPHEX (51 patients)
ADRIAMYCIN PFS (51 patients)
FENTANYL-100 (51 patients)
FLUTICASONE PROPIONATE (51 patients)
DIOVAN HCT (50 patients)
PROVERA (50 patients)
MORPHINE SULFATE (49 patients)
LOVENOX (49 patients)
TENORMIN (49 patients)
LANSOPRAZOLE (49 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ADENINE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about FIBROMYALGIA and ADENINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ADENINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ADENINE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ADENINE experts. If you are a healthcare provider experienced in prescribing ADENINE, please register here.
giCould not connect: